- Home
- CRIS vs FRSX Comparison
CRIS vs FRSX Comparison
Compare CRIS & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRIS | FRSX |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 6.3M |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CRIS | FRSX |
|---|---|---|
| Price | $1.20 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 110.0K | ★ 562.5K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,650,000.00 | $452,000.00 |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.56 | N/A |
| 52 Week Low | $1.02 | $1.75 |
| 52 Week High | $4.50 | $18.41 |
Technical Indicators
Market Signals| Indicator | CRIS | FRSX |
|---|---|---|
| Relative Strength Index (RSI) | 40.13 | 38.12 |
| Support Level | $1.29 | $1.76 |
| Resistance Level | $1.41 | $1.88 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 23.54 | 26.09 |
Price Performance
Historical ComparisonAbout CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.